94569 ⎘
Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Sub-classes:RAS INHIBITORS
#2WORKFLOW FOR GENERATING COMPOUNDS WITH BIOLOGICAL ACTIVITY AGAINST A SPECIFIC BIOLOGICAL TARGET
#3RAS INHIBITORS
#4MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS
#5Ras inhibitors
#6RADIO-AND CHEMO-PROTECTIVE COMPOUNDS
#7MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#8Ras inhibitors
#9Workflow for generating compounds with biological activity against a specific biological target
#10Unique self-assembled poly-amidoamine polymers and their eletrochemical reactivity
#11Chiral cyclodecynes and methods
#12MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#13Organic electroluminescent materials and devices
#14HCV NS-3 serine protease inhibitors
#15Unique self-assembled poly-amidoamine polymers and their electrochemical reactivity
#16Macrocyclic inhibitors of hepatitis C virus
#17Materials for electronic devices
#18Macrocyclic factor VIIa inhibitors
#19ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME
#20Antiaromatic compound and organic light-emitting device including the same
#21Antiaromatic compounds and organic light-emitting devices comprising the same
#22Macrocyclic inhibitors of hepatitis C virus
#23Dual small molecule inhibitors of cancer and angiogenesis
#24Macrocyclic inhibitors of hepatitis C virus
#25Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis
#26Compounds, monomers, and polymers containing a carbonate linkage
#27Thionating agent
#28Thionation process and a thionating agent
#29New polyamide, polyimide or polyamide-imide comprising dibenzodiazocine units
#30NON-NATURAL MACROCYCLIC AMIDE HDAC6 INHIBITOR COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS
#31[1,5]-diazocin derivatives
#32Dual small molecule inhibitors of cancer and angiogenesis
#33Macrocylic inhibitors of hepatitis C virus
#34PEPTOID COMPOUNDS
#35Macrocyclic inhibitors of hepatitis C virus
#36Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis
#37PEPTOID COMPOUNDS
#38HCV NS-3 SERINE PROTEASE INHIBITORS
#39HCV inhibiting macrocyclic phenylcarbamates
#40HCV NS-3 Serine Protease Inhibitors
#41Macrocyclic inhibitors of hepatitis C virus
#42MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS
#43Oximyl macrocyclic derivatives
#44Carbocyclic oxime hepatitis C virus serine protease inhibitors
#45Macrocylic inhibitors of hepatitis C virus
#46Macrocyclic inhibitors of hepatitis C virus
#47Macrocyclic inhibitors of hepatitis C virus
#48Macrocyclic compounds useful as BACE inhibitors
#49Macrocyclic inhibitors of hepatitis C virus
#50QUINOXALINYL MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS
#51Antibacterial amide macrocycles VI
#52Tetracyclic indole derivatives as antiviral agents
#53Macrocyclic Compounds Useful as Bace Inhibitors
#54Macrocyclic hepatitis C virus serine protease inhibitors
#55Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
#56Dual small molecule inhibitors of cancer and angiogenesis
#57Macrocyclic factor VIIa inhibitors useful as anticoagulants
#58HCV NS-3 serine protease inhibitors
#59HCV NS-3 serine protease inhibitors
#60Methods of determining βtubulin expression
#61Antibacterial amide macrocycles
#62Peptoid compounds
#63Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
#64Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
#65Peptoid compounds